Accessibility Menu
Cingulate logo

Cingulate

(NASDAQ) CING

Current Price$4.92
Market Cap$66.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-100%
5 YearN/A
1 Year+11%
1 Month+0%

Cingulate Financials at a Glance

Market Cap

$66.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$27.71M

EPS (TTM)

-$4.26

P/E Ratio

-1.15

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.92

Volume

0

Open

$4.90

Previous Close

$4.92

Daily Range

$4.72 - $4.95

52-Week Range

$3.16 - $11.89

Estimated Earnings Date

Aug 18, 2026

CING News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cingulate

Industry

Pharmaceuticals

Employees

14

CEO

Shane J. Schaffer, PharmD

Headquarters

Kansas City, KS 66205, US

CING Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-365.16%

Return on Capital

-176.51%

Return on Assets

-89.80%

Earnings Yield

-86.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$66.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

13.47M

Volume

0

Avg. Volume

567.27K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$24.16M

EBITDA

-$23.66M

Operating Cash Flow

-$19.55M

Capital Expenditure

-$223.31K

Free Cash Flow

-$19.77M

Cash & ST Invst.

$25.89M

Total Debt

$7.43M

Cingulate Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$66.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$5.09M

N/A

Employees

13

N/A

Net Income

-$9.31M

-141.7%

EBITDA

-$7.80M

-120.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$25.89M

+172.0%

Total Debt

$7.43M

+46.2%

Accounts Receivable

$53.94K

+29.7%

Inventory

$0.00

N/A

Long Term Debt

$1.04M

+12.1%

Short Term Debt

$6.39M

+53.8%

Return on Assets

-89.80%

N/A

Return on Invested Capital

-1.21%

N/A

Free Cash Flow

-$6.97M

-51.3%

Operating Cash Flow

-$6.91M

-50.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LIXTLixte Biotechnology Holdings, Inc.
$7.21-6.00%
ALLRAllarity Therapeutics, Inc.
$1.17-2.92%
ENTOEntero Therapeutics, Inc.
$2.85-5.00%
SYBXSynlogic, Inc.
$0.71-0.42%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.44-0.04%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.78-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.09+0.01%
RIVNRivian Automotive
$17.48-0.04%

Questions About CING

What is the current price of Cingulate?

Cingulate is trading at $4.92 per share.

What is the 52-week range for Cingulate?

Over the past 52 weeks, Cingulate has traded between $3.16 and $11.89.

How much debt does Cingulate have?

As of the most recent reporting period, Cingulate reported total debt of $7.43M.

How much cash does Cingulate have on hand?

Cingulate reported $25.89M in cash and cash equivalents in its most recent financial results.

What is Cingulate’s dividend yield?

Cingulate does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.